Filing Details

Accession Number:
0001725160-22-000159
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-12 16:26:47
Reporting Period:
2022-08-10
Accepted Time:
2022-08-12 16:26:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1725160 Zentalis Pharmaceuticals Inc. ZNTL Pharmaceutical Preparations (2834) 823607803
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1807484 D. Kevin Bunker C/O Zentalis Pharmaceuticals, Inc.
1359 Broadway Suite 1710
New York NY 10018
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-08-10 5,000 $30.00 95,000 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 764,110 Direct
Common Stock 350 Indirect As UTMA custodian for sons
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires October 31, 2022.
  2. Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any.